<h4>Background</h4>Targeted osmotic lysis (TOL) is a novel technology that involves concomitant stimulation of voltage-gated sodium channels (VGSCs) and the pharmacological blockade of Na<sup>+</sup>, K<sup>+</sup>-ATPase causing lysis of highly malignant cancer cells. The gene discussed is DNAH8; the disease is cancer.